MeMed vs Scopio Labs

MeMed vs Scopio Labs, compared side by side on 23 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: MeMed is on 61/100 and Scopio Labs on 61/100.

MeMed logo
MeMedMeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.
Try MeMed
Scopio Labs logo
Scopio LabsScopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.
Try Scopio Labs

Where each one leads

MeMed

  • agent readiness: 35/100 against 21/100
  • domain rating: 46/100 against 37/100
  • funding raised: $196M against $125M

Scopio Labs

  • headcount: 163 against 99
  • headcount growth: +9.8% against -8.4%
  • LinkedIn following: 29,818 against 21,207

At a glance

MeasureMeMedScopio Labs
What it isMeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.Scopio Labs transforms cell morphology analysis with fully digital platforms and diagnostic support for faster, more accurate disease detection.
CategoryHealthcare, Blood, Diagnostics, MedTechHealthcare, Diagnostics, Computational Microscopes, Medical Imaging
Sells toBusiness modelB2B, B2GB2B
OfferingSoftware, HardwareHardware, Software
Founded20092014
HeadquartersTirat Carmel, IsraelTel Aviv, Israel
StatusActiveActive

Size, funding and growth

MeasureMeMedScopio Labs
Employees99163
Headcount growthLast 12 months-8.4%+9.8%
Total funding$196M$125M
Latest roundSeries ESeries D
LinkedIn followers21,20729,818

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureMeMedScopio Labs
StartupHub scoreOur 0-100 rating61/10061/100
Traction60/10060/100
Team70/10070/100
Search visibility29/10034/100
Quality65/10065/100
Agent readinessHow well an AI agent can read and act on the siteF (35/100)F (21/100)
Domain ratingLink authority, 0-10046/10037/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureMeMedScopio Labs
HostingSelf ManagedSelf Managed
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4, Google Tag ManagerGoogle Tag Manager, Facebook Pixel
Support stackNot detectedZendesk

MeMed vs Scopio Labs: common questions

Which is better, MeMed or Scopio Labs?

Both score the same on our 0-100 rating, so the choice comes down to the 23 data points in the tables above rather than overall company strength.

How do MeMed and Scopio Labs compare on the numbers?

MeMed leads on agent readiness (35/100 against 21/100), domain rating (46/100 against 37/100), funding raised ($196M against $125M). Scopio Labs leads on headcount (163 against 99), headcount growth (+9.8% against -8.4%), LinkedIn following (29,818 against 21,207).

Read the full MeMed review and pricing or the Scopio Labs review and pricing. You can also browse other MeMed alternatives we track.